| abstract |
The present invention relates to quinoxalinone derivatives of formula (I) as insulin secretion stimulators, wherein R1, R2, R3, R4, R5 and R6 are as defined in claim 1. The invention also relates to the preparation and use of these quinoxalinone derivatives for preventing and / or treating diabetes and related pathologies. Other preferred compounds are compounds of general formula (I) in which R1, R2, R3, R4, R5 and R6 may be substituted by one or more groups selected from Z. |